RECURSION PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $3.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-25
- RECURSION PHARMACEUTICALS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $3.31M, a 115.37% increase from fiscal 2024.
- RECURSION PHARMACEUTICALS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $1.53M, a 11.07% decline from fiscal 2023.
- RECURSION PHARMACEUTICALS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $1.73M, a 111.00% increase from fiscal 2022.
- RECURSION PHARMACEUTICALS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $818.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $3.31M 10-K · filed 2026-02-25 |
| 2024-12-31 | $1.53M 10-K · filed 2026-02-25 |
| 2023-12-31 | $1.73M 10-K · filed 2025-02-28 |
| 2022-12-31 | $818.00K 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |